27 March 2019 | News
Veeda Clinical Research has successfully cleared 60 regulatory audits in the last 14 years including 19 USFDA Inspections of its facilities and clinical trial sites in last 24 months.
Representative Image
Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announced that its clinical (Shivalik, Ahmedabad) and Bioanalytical facilities (Insignia, Ahmedabad) have successfully completed the third inspection by NPRA (Malaysian Regulatory Agency).
This was a routine study inspection by the NPRA to verify the compliance of the facilities and the studies with the principles of Good Clinical Practices and applicable Good Laboratory Principles. The inspection outcome confirmed Veeda's commitment to the highest Quality standards and compliance with the defined SOPs and regulatory guidelines.
Veeda Clinical Research has successfully cleared 60 regulatory audits in the last 14 years including 19 USFDA Inspections of its facilities and clinical trial sites in last 24 months.
With its focus on sustaining a strong Quality Culture that underscores its Quality Policy and robust Quality Management System, Veeda continues to steadfastly pursue its mission – 'To Strive for Excellence in Quality and endeavour to become the partner of choice for our Sponsors and our Stakeholders'.